Chronic Intermittent Hypoxia and Hyperalgesic Priming - Administrative Supplement
Chronic Intermittent Hypoxia and Hyperalgesic Priming - Administrative Supplement
批准号:
10844191
负责人:
NATHANIEL Aaron JESKE
金额:
$1.6万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-03-01 至 2028-02-29
关键词:
18 year oldAbateAdministrative SupplementAffectAfferent NeuronsAmericanAnti-Inflammatory AgentsApplications GrantsBehaviorBehavioralBiochemicalBiological AssayCell SeparationChemicalsChronicClinicalClinical ResearchComplementContinuous Positive Airway PressureDNADNA BindingDangerousnessDensitometryDevelopmentDiagnosisEnvironmentExtramural ActivitiesFilmFixativesFriendsFundingFutureGelGenetic ScreeningHealthHypoxiaImageImmuneIn VitroInflammatoryKnowledgeLaboratoriesLifeLinkLocationMacrophageMaintenanceMeasuresMembraneMissionModelingMolecular GeneticsMusNational Institute of Neurological Disorders and StrokeNeuroimmuneNeuronal PlasticityNeuronsNociceptorsObstructive Sleep ApneaOxidative StressPainPathogenicityPatientsPatternPeripheralPersistent painPersonal SatisfactionPharmacology StudyPharmacotherapyPhasePhenotypePhysiologicalPilot ProjectsPopulationProteinsProteomicsPublic HealthPumpQuality of lifeRNARecurrenceReproducibilityResearchRodentRoentgen RaysRoleSamplingScanningServicesSignal PathwaySleepSleep DisordersSleep disturbancesSystemTechnologyTestingTissue SampleTissuesTranscriptTranslatingUnited States National Institutes of HealthUp-RegulationVisualizationWestern BlottingWorkX-Ray Filmchronic painclinical diagnosiscomorbiditycostdigitaldigital imagingexperimental studyhealth determinantshypoxia inducible factor 1image processingimagerimaging systemimprovedin vivoin vivo imaginginducible Creinnovationmolecular markermultidisciplinarynanoGoldnanoparticle drugnew technologynocturnal Hypoxemiapain behaviorpain chronificationpain sensationpreclinical studyprotein biomarkersprotein expression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Our current extramural funding, through NINDS, R01 NS128574, entitled Chronic Intermittent Hypoxia and
Hyperalgesic Priming, incorporates multiple proteomic experiments that depend on the visualization and
quantification of protein expression patterns across multiple in vitro and in vivo tissue samples. Furthermore,
Western blotting experiments are utilized throughout the grant proposal to support key experiments that track
peripheral neuron and macrophage protein marker expression profiles. Unfortunately, our main piece of
machinery for processing and visualizing Western blot membranes has come under a state of irreversible
disrepair, and we require immediate replacement to continue experiments proposed in the application.
We currently house an 18-year-old MiniMedical Services X-ray developer and processor to visualize Western
blot membranes. This developer requires monthly service to clean and replace reservoirs with environmentally-
dangerous developer and fixative solutions to produce films that are then digitally scanned and quantified for
band densitometry by NIH Image 1.62 to determine protein expression patterns. Several months ago, 2 of the
three necessary reservoir pumps failed. The cost to replace the broken pumps are estimated by service
technicians to cost more than a brand-new machine, thereby forcing us to discontinue its use in our laboratory
for proteomic research.
We have since solicited bids to determine how we might replace the broken developer with a chemiluminescence
imager. We received several quotes from multiple companies and submit the attached quote for your
consideration. The ThermoFisher Life Technologies iBright CL750 Digital Imaging System is an economical
replacement for the outdated MiniMed X-ray developer. This imaging system allows for imaging of
chemiluminescent Western blots, protein gels, and DNA gels, and supersedes the requirement for multi-
instrumental image processing (X-ray film to digital scanner) by integrating the image and sample analysis in
one machine. This is expected to significantly improve experimental rigor and reproducibility by reducing
sampling variables that can be inadvertently introduced during handling between multiple machines.
Furthermore, this technology is much more environmentally friendly by avoiding the need for dangerous chemical
disposal.
We respectfully submit this request for Administrative Supplemental Funding to continue NINDS-funded research
with new technology that will reduce our environmental footprint and increase rigor and reproducibility to conduct
work vital to the completion of the proposed studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chronic Intermittent Hypoxia and Hyperalgesic Priming
-
批准号:10655935
-
项目类别:
-
资助金额:$62.93万
-
财政年份:2023
-
负责人:NATHANIEL Aaron JESKE
-
依托单位:
Scaffolding Opiate Analgesia
-
批准号:9164537
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2016
-
负责人:NATHANIEL Aaron JESKE
-
依托单位:
Scaffolding the Transition to Chronic Pain
-
批准号:9263031
-
项目类别:
-
资助金额:$30.97万
-
财政年份:2013
-
负责人:NATHANIEL Aaron JESKE
-
依托单位:
Scaffolding the Transition to Chronic Pain
-
批准号:8664950
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2013
-
负责人:NATHANIEL Aaron JESKE
-
依托单位:
Scaffolding the Transition to Chronic Pain
-
批准号:8687906
-
项目类别:
-
资助金额:$2.17万
-
财政年份:2013
-
负责人:NATHANIEL Aaron JESKE
-
依托单位:
Scaffolding the Transition to Chronic Pain
-
批准号:8577841
-
项目类别:
-
资助金额:$38.44万
-
财政年份:2013
-
负责人:NATHANIEL Aaron JESKE
-
依托单位:
Scaffolding the Transition to Chronic Pain
-
批准号:9052231
-
项目类别:
-
资助金额:$31.41万
-
财政年份:2013
-
负责人:NATHANIEL Aaron JESKE
-
依托单位:
AKAP MODULATES TRPV1 PHOSPHORYLATION AND SENSITIZATION
-
批准号:8049940
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2008
-
负责人:NATHANIEL Aaron JESKE
-
依托单位:
AKAP MODULATES TRPV1 PHOSPHORYLATION AND SENSITIZATION
-
批准号:7643087
-
项目类别:
-
资助金额:$32.47万
-
财政年份:2008
-
负责人:NATHANIEL Aaron JESKE
-
依托单位:
AKAP MODULATES TRPV1 PHOSPHORYLATION AND SENSITIZATION
-
批准号:7531592
-
项目类别:
-
资助金额:$32.38万
-
财政年份:2008
-
负责人:NATHANIEL Aaron JESKE
-
依托单位:
AKAP MODULATES TRPV1 PHOSPHORYLATION AND SENSITIZATION
-
批准号:8099576
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2008
-
负责人:NATHANIEL Aaron JESKE
-
依托单位:
Cannabinoid-Induced Desensitization of TRPV1 Receptors
-
批准号:7130901
-
项目类别:
-
资助金额:$3.51万
-
财政年份:2005
-
负责人:NATHANIEL Aaron JESKE
-
依托单位:
Cannabinoid-Induced Desensitization of TRPV1 Receptors
-
批准号:6887256
-
项目类别:
-
资助金额:$4.48万
-
财政年份:2005
-
负责人:NATHANIEL Aaron JESKE
-
依托单位:
Integrins and mechanoreception in the inflames TMJ.
-
批准号:7065705
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2003
-
负责人:NATHANIEL Aaron JESKE
-
依托单位:
海外基金